Terry Smith, MD, Principal Investigator
May 4, 2017

Study: ‘Breakthrough’ Drug Reduces Graves’ Eye Disease Symptoms

A clinical trial led by the Terry Smith, MD at the University of Michigan Kellogg Eye Center offers hope for those with moderate to severe active thyroid eye disease (TED), also known as Graves’ eye disease. Patients had a significant reduction in symptoms after treatment with teprotumumab, a study drug the Food and Drug Administration